Management of Liver Metastases
Liver metastasis indicates a poor prognosis in patients with advanced or recurrent gastric cancer. Therefore, treatment for a primary lesion of gastric cancer, including gastrectomy and lymphadenectomy, has sometimes not been undertaken because of the presence of liver metastases. New approaches to treat patients with liver metastases, such as hepatic resection, second-generation combination systemic chemotherapy, and hepatic arterial infusion chemotherapy, have sometimes shown good control of liver metastases and have produced long survivals. These advances in the treatment of liver metastases have changed the therapeutic strategy for gastric cancer patients with liver metastases.
KeywordsGastric Cancer Liver Metastasis Hepatic Artery Hepatic Resection Systemic Chemotherapy
Unable to display preview. Download preview PDF.
- 3.Jacques Wils (1996) The treatment of advanced gastric cancer. Semin Oncol 23:397–406Google Scholar
- 4.Arai Y, Inaba Y, Takeuchi Y (1997) Interventional techniques for hepatic arterial infusion chemotherapy. In: Castaneda-Zuniga WR (ed) Interventional radiology, 3rd edn. Williams & Wilkins, Baltimore, pp 192–205Google Scholar
- 6.Arai Y, Sone Y, Tohyama N, et al (1992) Hepatic arterial infusion for unresectable liver metastases from gastric cancer. Proc ASCO 11:176Google Scholar
- 7.Ito K, Arai Y, Kumada T, et al (1994) Multi-institutional study of hepatic arterial infusion chemotherapy for liver metastases from gastric cancer using 5-FU, EPIR and MMC. Jpn J Cancer Chemother 30:1377Google Scholar
- 8.Horn DC, Stagg RJ, Friedman MA, et al (1989) A randomized trial of continuous intravenous versus hepatic intraarterial floxuridine in patients with colorectal cancer metastatic to the liver: the Northern California Oncology Group trial. J Clin Oncol 7:1646–1654Google Scholar
- 15.Patt YZ (1991) Regional hepatic arterial chemotherapy for colorectal cancer metastatic to the liver: the controversy continues. J Clin Oncol 11:815–819Google Scholar